Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 18

Trial Status

Completed9
Other1

Role Distribution

Principal Investigator7
Other Roles3
PI Rate70%

Activity Timeline

Clinical Trials (10)

NCT06132386Completed
Analysis of Cellular Kinases and Aging in PBMCs and Colorectal Tissue
AgingHIV Infections
PrincipalinvestigatorStart date: 2023-08-07
NCT04016233Phase 1Completed
Tenofovir Rectal Douche to Prevent HIV Transmission
HIV PreventionHIV/AIDS
PrincipalinvestigatorStart date: 2020-01-10
NCT03082690Phase 1Completed
ImQuest (IQP) DuoGel Phase 1 Pharmacokinetic Study
HIV Prevention
PrincipalinvestigatorStart date: 2017-11-01
NCT00696618Not ApplicableCompleted
Enema Use and Acceptability in HIV Negative Men Who Have Sex With Men
HIV Infections
Principalinvestigator
NCT03834909Phase 1Withdrawn
Pre-Exposure Prophylaxis Dosing in Pregnancy to Optimize HIV Prevention (PREP-P)
HIV-1-infectionPregnancy
Principalinvestigator

Research Network

Collaboration Network

4 collaborators·4 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Johns Hopkins University

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Publications (0)

No publications found for this investigator.

Clinical Trials (10)

Showing 10 of 10 trials

NCT06132386PrincipalInvestigator

Analysis of Cellular Kinases and Aging in PBMCs and Colorectal Tissue

AgingHIV Infections
Completed
NCT04016233Phase 1PrincipalInvestigator

Tenofovir Rectal Douche to Prevent HIV Transmission

HIV PreventionHIV/AIDS
Completed
NCT03408899Phase 1StudyChair

Evaluating the Safety and Pharmacokinetics of PC-1005 Administered Rectally to HIV-1 Seronegative Adults

HIV Infections
Completed
NCT03082690Phase 1PrincipalInvestigator

ImQuest (IQP) DuoGel Phase 1 Pharmacokinetic Study

HIV Prevention
Completed
NCT03060785Phase 1PrincipalInvestigator

Finding the Right Tenofovir/Emtricitabine Regimen for Pre-Exposure Prophylaxis (PrEP) in Transgender Women

HIV Prevention
Completed
NCT00063804Phase 1StudyChair

Safety of AMD070 When Administered Alone or Boosted With Low-Dose Ritonavir in HIV Uninfected Men

HIV Infections
Completed
NCT00696618Not ApplicablePrincipalInvestigator

Enema Use and Acceptability in HIV Negative Men Who Have Sex With Men

HIV Infections
Completed
NCT01276600Phase 1StudyChair

Dose-Proportionality and Intra-Individual Variability of Intracellular TFV-DP and FTC-TP in Healthy Volunteers

HIV
Completed
NCT01575418Phase 1PrincipalInvestigator

An Exploratory Rectal Safety Study of Three Tenofovir Gel Formulations

HIV Prevention
Completed
NCT03834909Phase 1PrincipalInvestigator

Pre-Exposure Prophylaxis Dosing in Pregnancy to Optimize HIV Prevention (PREP-P)

HIV-1-infectionPregnancy
Withdrawn

All 10 trials loaded